G-CSF and G-CSF Biosimilars Market, Global Outlook and Forecast 2023-2030

G-CSF and G-CSF Biosimilars Market, Global Outlook and Forecast 2023-2030

Published On : december 2023

Email: help@24marketreports.com

Report Studies • The global G-CSF and G-CSF Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

• G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.

Email: help@24marketreports.com

Call: +1(646)-781-7170 (Int'l)

By Types

Blood Disorders

Oncology Diseases

Chronic And Autoimmune Diseases

Growth Hormone Deficiencies

Email: help@24marketreports.com

Call: +1(646)-781-7170 (Int'l)

By Applications • Human Growth Hormone • Erythropoietin • Monoclonal Antibodies • Insulin • Interferon

$50,000 $40,000

$30,000 $25,000

$30,000 $20,000

$20,000 $15,000 $10,000

$10,000 $0

Email: help@24marketreports.com

$35,000

Call: +1(646)-781-7170 (Int'l)

$5,000 $0

Get in touch help@24marketreports.com

Call :

Call :

E-mail:

+1(646)-781-7170 (Int'l)

+91 8087042414 (Asia)

URL: www.24marketreports.com

Full Report URL: https://www.24marketreports.com/life-sciences/global-gcsf-gcsf-biosimilarsforecast-2023-2030-752 ©All Rights Reserved, 24 Market Reports